News-Medical.Net on MSN
GLP-1 weight-loss drugs show early promise for treating addiction
This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential ...
Eli Lilly has further expanded its weight-loss initiatives with novel therapies such as orforglipron, an oral GLP-1 receptor ...
It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results